CN Patent

CN109906078B — (r)-2-氨基-3-苯丙基氨基甲酸酯的制剂

Assigned to Gaz Pharmaceutical Co ltd · Expires 2022-09-13 · 4y expired

What this patent protects

本发明涉及(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯的速释制剂和使用其治疗紊乱的方法。

USPTO Abstract

本发明涉及(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯的速释制剂和使用其治疗紊乱的方法。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN109906078B
Jurisdiction: CN
Classification: —
Expires: 2022-09-13
Drug substance claim: No
Drug product claim: No
Assignee: Gaz Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.